Related Experiment Video

Updated: Jul 17, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics

W Marston Linehan1, Peter A Pinto, Ramaprasad Srinivasan

  • 1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. wml@nih.gov

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 27, 2007
PubMed

Insights

Understanding kidney cancer gene pathways, including von Hippel Lindau (VHL) and c-Met, aids targeted therapy development. Studying inherited forms reveals genetic defects for effective treatment strategies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Kidney cancer encompasses diverse subtypes with distinct characteristics and genetic underpinnings.
  • Advances in understanding kidney cancer gene pathways are crucial for developing targeted therapies.
  • Inherited kidney cancer syndromes (VHL, hereditary papillary renal carcinoma, BHD, hereditary leiomyomatosis renal cell cancer) illuminate the genetic basis of the disease.

Purpose of the Study:

  • To explore the genetic basis of kidney cancer.
  • To highlight the importance of inherited kidney cancer syndromes in understanding disease mechanisms.
  • To emphasize the potential of targeted therapies based on identified gene pathways.

Main Methods:

  • Review of current research on kidney cancer genetics.
  • Analysis of inherited kidney cancer syndromes and their associated genes (VHL, c-Met, BHD, fumarate hydratase).
  • Evaluation of targeted therapeutic strategies for specific kidney cancer pathways.

Main Results:

  • Kidney cancer is a heterogeneous disease with diverse genetic causes.
  • Inherited syndromes provide insights into key genes like VHL, c-Met, BHD, and fumarate hydratase.
  • Targeting these specific pathways offers a promising therapeutic avenue.

Conclusions:

  • Targeted therapies hold significant promise for kidney cancer treatment.
  • Understanding the genetic landscape of kidney cancer is essential for personalized medicine.
  • Further research into VHL, c-Met, BHD, and fumarate hydratase pathways can lead to improved patient outcomes.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors06:24

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors

Published on: August 1, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...